Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists.

Bali A, Bansal Y, Sugumaran M, Saggu JS, Balakumar P, Kaur G, Bansal G, Sharma A, Singh M.

Bioorg Med Chem Lett. 2005 Sep 1;15(17):3962-5.

PMID:
16039125
[PubMed - indexed for MEDLINE]
2.

New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivatives.

Thomas AP, Allott CP, Gibson KH, Major JS, Masek BB, Oldham AA, Ratcliffe AH, Roberts DA, Russell ST, Thomason DA.

J Med Chem. 1992 Mar 6;35(5):877-85.

PMID:
1548677
[PubMed - indexed for MEDLINE]
3.

Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.

Shah DI, Sharma M, Bansal Y, Bansal G, Singh M.

Eur J Med Chem. 2008 Sep;43(9):1808-12. Epub 2007 Nov 22.

PMID:
18158200
[PubMed - indexed for MEDLINE]
4.

Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring.

Guo XZ, Shi L, Wang R, Liu XX, Li BG, Lu XX.

Bioorg Med Chem. 2008 Dec 15;16(24):10301-10. doi: 10.1016/j.bmc.2008.10.040. Epub 2008 Oct 22.

PMID:
18976926
[PubMed - indexed for MEDLINE]
5.

Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.

Wang JL, Zhang J, Zhou ZM, Li ZH, Xue WZ, Xu D, Hao LP, Han XF, Fei F, Liu T, Liang AH.

Eur J Med Chem. 2012 Mar;49:183-90. doi: 10.1016/j.ejmech.2012.01.009. Epub 2012 Jan 17.

PMID:
22309912
[PubMed - indexed for MEDLINE]
6.

Synthesis and angiotensin II receptor antagonistic activities of benzimidazole derivatives bearing acidic heterocycles as novel tetrazole bioisosteres.

Kohara Y, Kubo K, Imamiya E, Wada T, Inada Y, Naka T.

J Med Chem. 1996 Dec 20;39(26):5228-35.

PMID:
8978851
[PubMed - indexed for MEDLINE]
7.

6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.

Ries UJ, Mihm G, Narr B, Hasselbach KM, Wittneben H, Entzeroth M, van Meel JC, Wienen W, Hauel NH.

J Med Chem. 1993 Dec 10;36(25):4040-51.

PMID:
8258826
[PubMed - indexed for MEDLINE]
8.

Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.

Zhang J, Wang JL, Zhou ZM, Li ZH, Xue WZ, Xu D, Hao LP, Han XF, Fei F, Liu T, Liang AH.

Bioorg Med Chem. 2012 Jul 15;20(14):4208-16. doi: 10.1016/j.bmc.2012.05.056. Epub 2012 Jun 5.

PMID:
22727371
[PubMed - indexed for MEDLINE]
9.

Nonpeptidic angiotensin II AT₁ receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles.

Zhang J, Wang JL, Yu WF, Zhou ZM, Tao WC, Wang YC, Xue WZ, Xu D, Hao LP, Han XF, Fei F, Liu T, Liang AH.

Eur J Med Chem. 2013 Nov;69:44-54. doi: 10.1016/j.ejmech.2013.08.014. Epub 2013 Aug 19.

PMID:
24007859
[PubMed - indexed for MEDLINE]
10.

Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.

Kaur N, Kaur A, Bansal Y, Shah DI, Bansal G, Singh M.

Bioorg Med Chem. 2008 Dec 15;16(24):10210-5. doi: 10.1016/j.bmc.2008.10.056. Epub 2008 Oct 29.

PMID:
19013821
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.

Ogino Y, Ohtake N, Nagae Y, Matsuda K, Moriya M, Suga T, Ishikawa M, Kanesaka M, Mitobe Y, Ito J, Kanno T, Ishihara A, Iwaasa H, Ohe T, Kanatani A, Fukami T.

Bioorg Med Chem Lett. 2008 Sep 15;18(18):5010-4. doi: 10.1016/j.bmcl.2008.08.018. Epub 2008 Aug 12.

PMID:
18723347
[PubMed - indexed for MEDLINE]
12.

Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists.

Wu WL, Burnett DA, Caplen MA, Domalski MS, Bennett C, Greenlee WJ, Hawes BE, O'Neill K, Weig B, Weston D, Spar B, Kowalski T.

Bioorg Med Chem Lett. 2006 Jul 15;16(14):3674-8. Epub 2006 May 11.

PMID:
16690315
[PubMed - indexed for MEDLINE]
13.

A comparative molecular field analysis and molecular modelling studies on pyridylimidazole type of angiotensin II antagonists.

Yoo SE, Kim SK, Lee SH, Yi KY, Lee DW.

Bioorg Med Chem. 1999 Dec;7(12):2971-6.

PMID:
10658603
[PubMed - indexed for MEDLINE]
14.

Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.

Bai R, Wei Z, Liu J, Xie W, Yao H, Wu X, Jiang J, Wang Q, Xu J.

Bioorg Med Chem. 2012 Aug 1;20(15):4661-7. doi: 10.1016/j.bmc.2012.06.011. Epub 2012 Jun 15.

PMID:
22750010
[PubMed - indexed for MEDLINE]
15.

Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists.

Ogino Y, Ohtake N, Nagae Y, Matsuda K, Ishikawa M, Moriya M, Kanesaka M, Mitobe Y, Ito J, Kanno T, Ishihara A, Iwaasa H, Ohe T, Kanatani A, Fukami T.

Bioorg Med Chem Lett. 2008 Sep 15;18(18):4997-5001. doi: 10.1016/j.bmcl.2008.08.021. Epub 2008 Aug 13.

PMID:
18752943
[PubMed - indexed for MEDLINE]
16.

Synthesis and structure-activity relationship of a new series of potent angiotensin II receptor antagonists: pyrazolo[1,5-a]pyrimidine derivatives.

Shiota T, Yamamori T, Sakai K, Kiyokawa M, Honma T, Ogawa M, Hayashi K, Ishizuka N, Matsumura K, Hara M, Fujimoto M, Kawabata T, Nakajima S.

Chem Pharm Bull (Tokyo). 1999 Jul;47(7):928-38.

PMID:
10434395
[PubMed - indexed for MEDLINE]
17.

Design and synthesis of novel small molecule N/OFQ receptor antagonists.

Chen Z, Goehring RR, Valenzano KJ, Kyle DJ.

Bioorg Med Chem Lett. 2004 Mar 8;14(5):1347-51.

PMID:
14980696
[PubMed - indexed for MEDLINE]
18.

Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluation.

Agelis G, Resvani A, Matsoukas MT, Tselios T, Kelaidonis K, Kalavrizioti D, Vlahakos D, Matsoukas J.

Amino Acids. 2011 Feb;40(2):411-20. doi: 10.1007/s00726-010-0651-y. Epub 2010 Jul 6.

PMID:
20607324
[PubMed - indexed for MEDLINE]
19.

The conformation and activity relationship of benzofuran type of angiotensin II receptor antagonists.

Yoo SE, Kim SK, Lee SH, Kim NJ, Lee DW.

Bioorg Med Chem. 2000 Sep;8(9):2311-6.

PMID:
11026543
[PubMed - indexed for MEDLINE]
20.

[Studies on the synthesis of cholecystokinin A receptor antagonists. IV. Synthesis and cholecystokinin A receptor inhibitory activities of benzimidazole derivatives].

Ajisawa Y, Akahane K, Akahane M, Sato K, Tamai T, Saito M, Tanaka N, Kamata K, Kobayashi M.

Yakugaku Zasshi. 1996 Sep;116(9):735-47. Japanese.

PMID:
8855719
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk